LATS antagonist | LATS inhibitor | LATS agonist |LATS activator

製品コード	製品名称	製品説明	文献中Selleckの製品使用例
E1314	TDI-011536	TDI-011536 is a potent Lats kinase inhibitor that interrupts Hippo-Yap signaling and promotes proliferation of lesioned cardiac muscle cells.	Nat Commun, 2024, 15(1):6953
E1061	TRULI	TRULI inhibits both Lats1 and Lats2 with a IC50 of 0.2 nM, suppresses Yap phosphorylation, induces cell proliferation in several cell lines and tissues, and promotes the initial stages of proliferative regeneration of the sensory receptors in the inner ear.	Nat Commun, 2024, 15(1):5449 Cell Rep, 2024, 43(4):114032 EMBO Rep, 2024, 25(9):4033-4061
E1145	GA-017	GA-017 inhibits the serine/threonine protein kinases large tumor suppressor kinase 1/2 (LATS1/2), which exerts inhibitory with IC50s against LATS1 and 2 of 4.10±0.79 and 3.92±0.42 nM, respectively, and competitively inhibits LATS1 and 2 against ATP, with Ki (inhibition constant) values of 0.58±0.11 and 0.25±0.03 nM, respectively.
E1314	TDI-011536	TDI-011536 is a potent Lats kinase inhibitor that interrupts Hippo-Yap signaling and promotes proliferation of lesioned cardiac muscle cells.	Nat Commun, 2024, 15(1):6953
E1061	TRULI	TRULI inhibits both Lats1 and Lats2 with a IC50 of 0.2 nM, suppresses Yap phosphorylation, induces cell proliferation in several cell lines and tissues, and promotes the initial stages of proliferative regeneration of the sensory receptors in the inner ear.	Nat Commun, 2024, 15(1):5449 Cell Rep, 2024, 43(4):114032 EMBO Rep, 2024, 25(9):4033-4061
E1145	GA-017	GA-017 inhibits the serine/threonine protein kinases large tumor suppressor kinase 1/2 (LATS1/2), which exerts inhibitory with IC50s against LATS1 and 2 of 4.10±0.79 and 3.92±0.42 nM, respectively, and competitively inhibits LATS1 and 2 against ATP, with Ki (inhibition constant) values of 0.58±0.11 and 0.25±0.03 nM, respectively.

LATS

LATS製品

LATS阻害剤の選択性比較